Mylan Institutional Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN INSTITUTIONAL, and what generic and branded alternatives to MYLAN INSTITUTIONAL drugs are available?
MYLAN INSTITUTIONAL has forty-six approved drugs.
Summary for Mylan Institutional
US Patents: | 0 |
Tradenames: | 41 |
Ingredients: | 39 |
NDAs: | 46 |
Patent Litigation for Mylan Institutional: | See patent lawsuits for Mylan Institutional |
PTAB Cases with Mylan Institutional as petitioner: | See PTAB cases with Mylan Institutional as petitioner |
Drugs and US Patents for Mylan Institutional
Expired US Patents for Mylan Institutional
Paragraph IV (Patent) Challenges for MYLAN INSTITUTIONAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 1 mg/vial, 2 mg/vial and 5 mg/vial | ➤ Subscribe | 2013-12-27 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Here is a list of applicants with similar names.